Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +4.90% | -0.93% | +23.70% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 166M | Capitalization | 125M |
---|---|---|---|---|---|
Net income 2024 * | -144M | Net income 2025 * | -131M | EV / Sales 2024 * | 0.86 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-1.08
x | Employees | 325 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Karyopharm Therapeutics Inc.
1 day | +4.90% | ||
1 week | -0.93% | ||
Current month | +3.88% | ||
1 month | -20.15% | ||
3 months | -20.15% | ||
6 months | +54.33% | ||
Current year | +23.70% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.07 | +4.90% | 1,503,994 |
24-05-08 | 1.02 | -7.27% | 2,639,086 |
24-05-07 | 1.1 | -4.35% | 990,027 |
24-05-06 | 1.15 | +1.77% | 848,584 |
24-05-03 | 1.13 | +4.63% | 983,372 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.70% | 125M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.88% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- KPTI Stock